ORCID as entered in ROS
https://orcid.org/0000-0002-5675-1810
Select Publications
Conference Papers
, 2023, ' Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of HCC', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A16 - A16, presented at
, 2023, ' Shifting patterns of hepatocellular carcinoma mortality risk: the impact of socioeconomic status and ethnicity in NSW, australia', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A21 - A22, presented at
, 2022, '10 GHz Compact Shunt-Diode Rectifier Circuit Using Thin Film Ag/AZO Schottky Barrier Diode for Energy Harvesting Applications', in Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics, pp. 436 - 445, http://dx.doi.org/10.1007/978-3-031-05014-5_36
, 2022, 'A 2 × 2 Array Antenna for Multi-band Energy Harvesting for Biomedical Sensing Applications', in Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics, pp. 462 - 471, http://dx.doi.org/10.1007/978-3-031-05014-5_38
, 2021, 'CONTRIBUTION OF NON-VIRAL AETIOLOGIES OF LIVER DISEASE TO THE GROWING BURDEN OF HEPATOCELLULAR CARCINOMA IN NEW SOUTH WALES', in HEPATOLOGY, WILEY, pp. 628A - 628A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'DISPARITIES IN OUTCOMES OF HEPATOCELLULAR CARCINOMA IN NEW SOUTH WALES BY SOCIOECONOMIC STATUS', in HEPATOLOGY, WILEY, pp. 634A - 635A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'METABOLIC RISK FACTORS ARE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER SURGICAL RESECTION', in HEPATOLOGY, WILEY, pp. 658A - 658A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Contribution of non-viral etiologies of liver disease to the growing burden of hepatocellular carcinoma in New South Wales', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 53 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Disparities in outcomes of hepatocellular carcinoma in New South Wales by socioeconomic status', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 17 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Metabolic risk factors are predictive of hepatocellular carcinoma recurrence after surgical resection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Role of metabolic syndrome in persistently elevated alanine aminotransferase levels in patients with suppressed hepatitis B infection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Community screening identifies undiagnosed chronic liver disease in high-risk populations', in Journal of Gastroenterology and Hepatology Australia, pp. 2255 - 2260, http://dx.doi.org/10.1111/jgh.15473
, 2020, 'SELECTIVE INTERNAL RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA IN AUSTRALIA - A 15-YEAR MULTICENTER COHORT STUDY.', in HEPATOLOGY, WILEY, ELECTR NETWORK, pp. 706A - 707A, presented at
, 2020, 'Selective internal radiation therapy for hepatocellular carcinoma in Australia: A 15-year multicenter cohort study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Underlying non-alcoholic fatty liver disease increases the risk of hepatocellular carcinoma recurrence after curative hepatic resection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 62 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'High rates of sustained virological response at 12 weeks in a real-world hospital-based cohort of direct-acting antiviral-treated patients with hepatitis C virus (HCV): The Observational, Prospective Epidemiological Registry in Australia of HCV (OPERA-C)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'How to manage pemphigus with pre-existing hepatitis B who needs rituximab therapy', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467967200098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Burden of disease in patients with advanced cirrhosis not suitable for transplant', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Response to mycophenolate mofetil in patients with autoimmune hepatitis who fail standard therapy is predicted by serum gammaglobulin levels but not by cirrhosis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 59 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'RESPONSE TO MYCPHENOLATE MOFETIL IN PATENTS WITH AUTOIMMUNE HEPATITIS WHO FAIL STANDARD THERAPY IS PREDICTED BY SERUM GAMMAGLOBULIN LEVELS BUT NOT CIRRHOSIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1213 - S1213, presented at
, 2018, 'Regional variability in the etiology of hepatocellular carcinoma: Opportunities for targeted interventions', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 16 - 16
, 2017, 'An Observational, Prospective Epidemiological Registry in Australia of HCV Liver Disease (OPERA-C)', in HEPATOLOGY, WILEY, DC, Washington, pp. 528A - 528A, presented at
, 2017, 'High rates of undiagnosed viral hepatitis and chronic liver disease in the community: A community-based study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Impact of a multidisciplinary team on surgical outcomes for patients undergoing curative surgery for hepatocellular carcinoma: A single-center experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 113 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S521 - S521, presented at
, 2016, 'Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV Genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL Study', in HEPATOLOGY, WILEY, MA, Boston, pp. 483A - 484A, presented at
, 2016, 'Frequency and severity of biochemical abnormalities with paritaprevir/ritonavir/ombitasvir +/- ribavirin in a real-world cohort of HCV Genotype 1 patients - predictors and clinical significance', in HEPATOLOGY, WILEY, MA, Boston, pp. 442A - 442A, presented at
, 2016, 'Mycophenolate Mofetil in Autoimmune Hepatitis Patients not Responsive or Intolerant to Standard Therapy: the Australian TAPESTRY study', in HEPATOLOGY, WILEY, MA, Boston, pp. 817A - 817A, presented at
, 2016, 'Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin', in HEPATOLOGY, WILEY, MA, Boston, pp. 455A - 456A, presented at
, 2016, 'Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 77 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Frequency and severity of hyperbilirubinaemia with Viekira Pak in a real-world cohort of HCV genotype 1 patients - Predictors and clinical significance', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 78 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Mycophenolate in autoimmune hepatitis not responsive or intolerant to standard therapy: the TAPESTRY study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 100 - 101, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'General practitioners face significant barriers to prescribing direct-acting antiviral therapy for hepatitis C', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 81 - 81
, 2016, 'Reliance on specialist care in the early roll-out of direct-acting antiviral therapy for hepatitis C', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 83 - 84
, 2015, 'C-SCAPE: EFFICACY AND SAFETY OF 12 WEEKS OF GRAZOPREVIR plus /- ELBASVIR plus /- RIBAVIRIN IN PATIENTS WITH HCV GT2, 4, 5 OR 6 INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S619 - S619, presented at
, 2014, 'Effect of metabolic syndrome on patients with viral hepatitis treated with local regional therapy for hepatocellular carcinoma', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 806A - 806A, presented at
, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 334A - 334A, presented at
, 2014, 'The Protease Fibroblast Activation Protein (FAP) in Liver Disease', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 592A - 592A, presented at
, 2014, 'Effect of metabolic syndrome on patients with viral hepatitis treated with local regional therapy for hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 78 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'The protease fibroblast activation protein (FAP) in liver disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'P427 POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s210, presented at
, 2013, 'Impaired T cell glucose metabolism during chronic hepatitis C virus infection', in Narci T (ed.), Journal of Gastroenterology and Hepatology, Wiley Online, Melbourne, Australia, pp. 171 - 171, presented at
, 2013, 'Hepatitis C patients with hepatocellular carcinoma undergoing transarterial chemoembolisation', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 64 - 64
, 2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 354A - 354A, presented at
, 2012, 'HEPATITIS C VIRUS-SPECIFIC EFFECTOR AND REGULATORY CD4+T CELLS IN PRIMARY INFECTION RESULTING IN CLEARANCE OR CHRONIC INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S317 - S317, presented at
, 2012, 'IMPAIRED T-CELL GLUCOSE METABOLISM DURING CHRONIC HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S302 - S302, presented at
, 2012, 'T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S313 - S313, presented at
, 2010, 'HEPATIC MICRORNA 135A*REGULATES HEPATIC TRIGLYCERIDE STORAGE AND IS REPRESSED DURING HCV INFECTION', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 727A, presented at
, 2010, 'SERUM PROTEOMIC PROFILES ASSOCIATED WITH IL28B GENOTYPE AMONG CHC PATIENTS', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 728A, presented at
, 2009, 'HEPATIC MICRORNAS EXPRESSION IN OBESE SUBJECTS WITH CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 940A - 940A, presented at
Filter by type
https://orcid.org/0000-0002-5675-1810